本文共1900 字 阅读完约7分钟 金融投资报记者 刘庆华 三季度行情即将收官。在经历了一季度的震荡上行，一季度末和二季度初的调整之后，A股市场和港股 市场自4月中旬以来持续走高，并在三季度迭创阶段新高，投向股票资产的基金也获得了不错的收益。 Wind数据显示，今年以来截至9月26日，在权益类基金和QDII基金中，合计共有37只基金收益率翻倍。 主动管理的A股权益类基金中，重仓AI的基金收益率领先，单只基金收益率最高接近190%。被动指数 型基金中，跟踪创新药、通信、人工智能等方向的基金收益率居前。 01 主动权益基金：31只基金收益翻倍 投向A股的主动权益类基金今年以来表现不俗，超额回报出色。截至9月26日，算术平均收益率为 30.32%（剔除年内成立的基金），超过98%的主动权益类基金取得正收益，收益率超50%的基金达到 684只，占比超15%。其中，收益率超过100%的基金有31只，单只基金最高收益率接近190%。 永赢科技智选A以189.58%的收益率领跑。二季度以来该基金净值涨幅明显，近半年的收益率超过了 164%。从基金季报可以看到，二季度末该基金有明显的调仓动作，前十大重仓股全部更换，将持仓重 ...

Core Viewpoint - Despite the strong performance of technology and pharmaceutical funds, public funds are gradually adopting a defensive mindset [1] Group 1: ETF Construction Strategies - The construction speed of popular industry ETFs has slowed down, with significant positions only around 10-17% before their respective listings [3][4] - As of September 19, 2023, the strongest technology funds have achieved returns of up to 196%, while pharmaceutical funds have exceeded 170% [3][4] - The rapid construction of ETFs is often linked to the performance of the underlying sectors, with slower construction occurring when sector gains are excessive [4] Group 2: Shift Towards Consumer Stocks - Leading funds are increasingly focusing on consumer stocks, with several pharmaceutical-themed funds beginning to include new consumer stocks in their portfolios [5][6] - The IPO of IFBH, a coconut water company, attracted significant interest from multiple public and private funds, indicating a shift in investment strategy [5] - The entry of public funds into consumer stocks is seen as a response to the strong performance of the innovative drug sector [6] Group 3: Outlook on Consumer Sector - The consumer sector is viewed as a core defensive asset for public funds, driven by the emergence of quality companies and new performance drivers [7][8] - Analysts suggest that the competitive landscape in the consumer industry may improve due to a weak economic environment, leading to better product innovation and operational efficiency [8] - The consumer sector is characterized by a vast domestic market and increasing international expansion, presenting new investment opportunities [8]

Group 1 - The core viewpoint indicates that despite strong performance in technology and pharmaceutical funds, some public funds are shifting towards a defensive strategy, with new consumption stocks potentially offering better investment safety [1][4] - The construction speed of popular thematic ETFs has slowed down significantly as stock prices rise, with specific ETFs showing low stock positions just before their listing [2][3] - The slowdown in ETF construction speed is attributed to the substantial gains in related sector funds, with technology funds achieving up to 196% and pharmaceutical funds over 170% year-to-date [3] Group 2 - Some funds are beginning to replace their holdings in pharmaceuticals and technology with defensive consumer stocks, indicating a strategic shift among fund managers [4][6] - Public funds have started to participate in the IPOs of consumer stocks, which was rare earlier in the year, suggesting a growing interest in the consumer sector [4][5] - The consumer sector is viewed as a key defensive asset for public funds, driven by reasonable valuations and the emergence of quality companies with new performance drivers [6][8] Group 3 - Fund managers believe that the third quarter will see a differentiation in market performance, emphasizing the importance of selecting quality companies as the market becomes more rational [7] - New consumption trends are characterized by a focus on consumer experience and the emergence of leading brands in the capital market, which could lead to sustained interest in these sectors [7][8] - The consumer industry is expected to benefit from clearer demand-side policies in the second half of the year, potentially leading to improved profitability and competitive dynamics [8]

Group 1 - The article highlights that foreign institutions, represented by Barclays and UBS, are actively investing in A-shares and Hong Kong stocks across various sectors, including gold, innovative pharmaceuticals, and semiconductors, with several thematic ETFs achieving high returns this year [2][4][5] - As of the end of Q2, Barclays has become the largest holder in 31 ETFs, focusing on themes such as gold stocks and Hong Kong technology [4][6] - The performance of thematic ETFs has been notable, with the Ping An CSI Hong Kong Gold Industry ETF yielding over 60% and the Huatai-PB Hang Seng Innovative Pharmaceutical ETF exceeding 100% returns year-to-date [4][5] Group 2 - UBS has diversified its investments across over 100 ETFs, including sectors like building materials, green energy, and agriculture, in addition to popular themes [7][8] - Foreign institutions view the Chinese market as an independent asset class, driven by global asset allocation and domestic policy support, which is expected to inject strong momentum into A-shares and Hong Kong stocks [9][8] - The article notes that the "dual carbon" goals are driving global green energy reforms, while advancements in AI and computing power are leading a new wave of technological innovation, creating significant demand for upstream resources [9][8]

Core Viewpoint - Foreign institutions are diversifying their investments in the A-share and Hong Kong stock markets through ETFs, achieving substantial returns in various hot sectors such as gold, innovative pharmaceuticals, and semiconductors [1][2]. Group 1: Heavy Investment in Hot Sectors - Barclays Bank has become the largest holder of 31 ETFs by the end of Q2, focusing on sectors like gold stocks, Hong Kong technology, and innovative pharmaceuticals [1]. - The Ping An CSI Hong Kong and Shanghai Gold Industry ETF, where Barclays holds 1.3134 million shares, has seen a return rate exceeding 60% this year [2]. - The Huatai-PineBridge Hang Seng Innovative Pharmaceutical ETF, with Barclays and UBS as major holders, has achieved a return rate over 100% this year [2]. Group 2: Semiconductor Sector Performance - The semiconductor sector has shown strong performance, with Barclays significantly increasing its holdings in the Guolian An Kechuang Chip Design ETF, becoming the sixth-largest holder by the end of Q2 [3]. - UBS has also increased its stake in the Jiashi Shanghai Stock Exchange Star Market Chip ETF, moving from the eighth to the seventh-largest holder [3]. - Both ETFs have reported returns exceeding 60% and 50% respectively this year [3]. Group 3: Diversified Investment Strategies - UBS has appeared in the top ten holders of over 100 ETFs, indicating a diverse investment strategy that includes sectors like building materials, traditional Chinese medicine, green energy, and agriculture [3]. - Foreign institutions are also exploring investment opportunities in the Hong Kong market, including sectors like automotive, consumer goods, finance, and the internet [3]. Group 4: Continued Inflow of Foreign Capital - Allianz Fund's CIO stated that Chinese assets are now viewed as a standalone asset class, with expectations of continued foreign capital inflow if profit-making effects persist and fundamentals improve [4]. - The recent market uptrend is attributed to favorable funding conditions and a shift in global asset allocation, alongside a transfer of household savings [5]. - Factors such as China's technological competitiveness and the resolution of potential risks in real estate are contributing to the positive sentiment among foreign investors [5]. Group 5: Outlook on Key Sectors - The technology sector is expected to see significant improvements in fundamentals, leading to excess returns in Q3, particularly in semiconductor equipment and other key areas [6]. - The dual carbon goals are driving a global green energy revolution, while advancements in artificial intelligence are leading a new wave of technological innovation [6]. - These trends are expected to create substantial demand for upstream resource products, which have faced supply shortages due to low capital expenditure in recent years [6].

Group 1 - Foreign institutions, represented by Barclays and UBS, are heavily investing in A-shares and Hong Kong stocks across popular sectors such as gold, innovative pharmaceuticals, and semiconductors, while also extending their reach into niche areas like building materials and green energy [1][3] - As of the end of Q2, Barclays has become the largest holder in 31 ETFs, focusing on themes like gold stocks and Hong Kong technology [3] - The performance of ETFs such as the Ping An CSI Hong Kong and Shanghai Gold Industry ETF has exceeded 60% year-to-date, with Barclays emerging as a significant holder [3] Group 2 - The semiconductor sector has shown strong performance, with ETFs like the Guolian Anke Innovation Chip Design ETF and the Jiashi Shanghai Stock Exchange Innovation Board Chip ETF yielding returns of over 60% and 50% respectively this year [4] - UBS has been involved in over 100 ETFs, diversifying its investments into various sectors including building materials, traditional Chinese medicine, green energy, and agriculture [6] - Foreign institutions are optimistic about Chinese assets, viewing the market as an independent asset class, driven by global asset allocation and domestic policy support [8]

Group 1 - Foreign institutions, represented by Barclays and UBS, are actively investing in A-shares and Hong Kong stocks across various sectors, including gold, innovative pharmaceuticals, and semiconductors, as well as niche areas like building materials and green energy [1][4] - As of the end of Q2, Barclays has become the largest holder in 31 ETFs, focusing on themes such as gold stocks, Hong Kong technology, and innovative pharmaceuticals [2] - The Ping An CSI Hong Kong Gold Industry ETF, where Barclays is the largest holder with 1.3134 million shares, has seen a return of over 60% year-to-date as of September 1 [2] Group 2 - The Hong Kong innovative pharmaceutical sector has attracted significant foreign investment, with Barclays and UBS being the top two holders of the Huatai-PineBridge Hang Seng Innovative Pharmaceutical ETF, which has returned over 100% year-to-date [2] - The semiconductor sector has shown strong performance, with ETFs like the Guolian Anke Innovation Chip Design ETF and the Harvest CSI Star Market Chip ETF yielding returns of over 60% and 50% respectively [3] - UBS has appeared in the top ten holders of over 100 ETFs, diversifying its investments into various niche sectors such as building materials, traditional Chinese medicine, green energy, and agriculture [4] Group 3 - Foreign institutions view the Chinese market as an independent asset class, driven by global asset allocation and domestic asset transfer [5] - The recent market uptrend is supported by expectations of U.S. Federal Reserve interest rate cuts and positive domestic policies, which are anticipated to inject strong momentum into A-shares and Hong Kong stocks [5] - The dual carbon goals are driving global green energy reforms, while advancements in artificial intelligence and computing power are leading a new wave of technological innovation, creating significant demand for upstream resources [5]

Core Viewpoint - The performance of Huatai-PB Fund in the first half of 2025 shows a significant decline in both revenue and net profit, highlighting the challenges faced by the company and the broader industry due to increased competition and changing market conditions [3][5][14]. Financial Performance - Huatai-PB Fund reported a revenue of 0.952 billion yuan in the first half of 2025, a decrease of 5% year-on-year [3][5]. - The net profit for the same period was 0.204 billion yuan, reflecting a substantial decline of 36.16% compared to the previous year [5][10]. - In contrast, the company achieved a revenue of 2.313 billion yuan and a net profit of 0.730 billion yuan for the entire year of 2024, indicating that the first half of 2025 only accounted for 28% of the previous year's net profit [5][14]. Market Position and Product Structure - Huatai-PB Fund maintains a leading position in the ETF market, with its Huatai-PB CSI 300 ETF reaching a scale of 419.682 billion yuan, significantly ahead of its closest competitor [6][10]. - Over 82% of the company's assets, amounting to 567.7 billion yuan, are concentrated in ETF products, which are known for their low management fees [8][10]. - The company has faced pressure from industry-wide fee reductions, impacting its revenue from management fees [8][10]. Industry Trends - The public fund industry is experiencing a trend of declining management fees, particularly for passive products like ETFs, which has led to increased competition and pressure on profit margins [8][10][14]. - The performance of Huatai-PB Fund reflects a broader industry challenge, where reliance on a single product line and scale expansion is becoming insufficient to withstand competitive pressures [14]. Investment Opportunities - Despite the overall decline in financial performance, Huatai-PB Fund's thematic ETFs, particularly in innovative sectors like pharmaceuticals and rare earths, have shown strong performance, indicating potential growth areas [12][14].

Core Insights - The article provides a ranking of open-end funds based on their net asset value growth as of August 20, 2025, highlighting the top and bottom performers in the market [2][4][6]. Fund Performance Summary - The top 10 funds with the highest net value growth include: 1. 嘉实绿色主题股票发起式A with a net value of 1.1888, up from 1.1232 [2] 2. 嘉实绿色主题股票发起式C with a net value of 1.1712, up from 1.1066 [2] 3. 宏利领先中小盘混合 with a net value of 0.9990, up from 0.9500 [2] 4. 中航远见领航混合发起C with a net value of 1.3618, down from 1.2951 [2] 5. 中航远见领航混合发起A with a net value of 1.3704, down from 1.3033 [2] 6. 国联安科创芯片设计ETF with a net value of 1.3214, up from 1.2581 [2] 7. 东方阿尔法优势产业混合A with a net value of 1.7251, up from 1.6440 [2] 8. 东方阿尔法优势产业混合C with a net value of 1.6814, up from 1.6024 [2] 9. 永赢半导体产业智选混合发起C with a net value of 1.4539, up from 1.3865 [2] 10. 永赢半导体产业智选混合发起A with a net value of 1.4715, up from 1.4033 [2] - The bottom 10 funds with the lowest net value growth include: 1. 申万赛信医药先锋股票C with a net value of 0.6109, down from 0.6369 [4] 2. 申万菱信医药先锋股票A with a net value of 0.6196, down from 0.6459 [4] 3. 华富健康文娱灵活配置混合C with a net value of 1.4777, down from 1.5389 [4] 4. 华富健康文娱灵活配置混合A with a net value of 1.4886, down from 1.5502 [4] 5. 红十创新医疗保健股票 with a net value of 1.5397, down from 1.5957 [4] 6. 东方阿尔法健康产业混合发起C with a net value of 1.1568, down from 1.1961 [4] 7. 东方阿尔法健康产业混合发起A with a net value of 1.1578, down from 1.1971 [4] 8. 恒生新药 with a net value of 2.0024, down from 2.0690 [4] 9. 金鹰责任投资混合A with a net value of 0.5689, down from 0.5876 [4] 10. 景顺长城医疗产业股票C with a net value of 1.6703, down from 1.7251 [4] Market Trends - The Shanghai Composite Index opened lower but rebounded, closing higher, while the ChiNext Index showed a W-shaped recovery with a slight increase [6]. - The total trading volume reached 2.44 trillion, with a market breadth of 3,676 gainers to 1,587 losers [6]. - Leading sectors included chemical fiber, semiconductors, and hotel catering, each with gains exceeding 3% [6].

Core Viewpoint - The average return rate of over 300 existing QDII funds in the public market for July 2025 is 3.95%, with significant performance variations among different funds [1][3]. Group 1: Top Performing QDII Funds - The top-performing QDII funds in July 2025 are primarily related to Hong Kong pharmaceutical assets, with the Huatai-PB Hang Seng Innovation Drug ETF achieving a return of 27.74% [2][3]. - The E Fund Global Pharmaceutical Industry RMB A fund also performed well, with a return of 27.47% in July [2][6]. - Other notable funds include the GF CSI Hong Kong Innovation Drug ETF and the Huitianfu Hong Kong Advantage Selection A, both with returns of 27.04% [2][3]. Group 2: Underperforming QDII Funds - Over 40 QDII funds experienced negative returns in July 2025, particularly those focused on the Indian and Japanese markets [11]. - The Manulife India fund had the largest decline, with a return of -3.84%, while the Huaan Mitsubishi Nikkei 225 ETF linked A saw a return of -2.19% [14]. - The GF Global Healthcare A RMB fund also faced a significant drop, with a return of -1.99% [14]. Group 3: Long-term Performance - Four active equity QDII products have achieved an annualized return of over 30% since their inception, including the Jiashi Global Industrial Upgrade A and the Southern Hong Kong Digital Economy A [7][8]. - The Jiashi Global Industrial Upgrade A fund, established in February 2023, has a strong focus on major tech stocks like NVIDIA and Micron Technology [8].